Kohjin Bio Co., Ltd. (TYO:177A)
Japan · Delayed Price · Currency is JPY 963.00
+1.00 (0.10%)
Jun 24, 2026, 3:30 PM JST
Kohjin Bio Market Cap
Kohjin Bio has a market cap or net worth of 4.92 billion as of June 24, 2026. Its market cap has decreased by -40.48% in one year.
Market Cap
4.92B
Enterprise Value
4.63B
Revenue
4.94B
Ranking
n/a
PE Ratio
19.61
Stock Price
963.00
Market Cap Chart
Since April 25, 2024, Kohjin Bio's market cap has decreased from 11.89B to 4.92B, a decrease of -58.58%. That is a compound annual growth rate of -33.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 4.92B | -35.33% |
| Dec 30, 2025 | 7.61B | -11.16% |
| Dec 30, 2024 | 8.57B | -27.92% |
| Apr 25, 2024 | 11.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kidswell Bio | 6.75B |
| Carna Biosciences | 6.49B |
| Soiken Holdings | 6.30B |
| BrightPath Biotherapeutics | 6.25B |
| CellSource | 6.23B |
| Noile-Immune Biotech | 5.25B |
| Chiome Bioscience | 5.00B |
| PRISM BioLab Co.,LTD | 4.81B |